Our Blog

Navigating the pharmaceutical industry’s complex regulatory framework requires expert guidance, especially in roles like Qualified Person (Q

Learn how to set up a WDA license for UK pharmaceutical distribution, covering MHRA steps, compliance, and sector-specific requirements

Setting up a pharmaceutical business in the UK or EU requires stringent regulatory compliance.

As the regulatory landscape continues to evolve post-Brexit, importing medicines into Great Britain from European Economic Area (EEA) states on the approved country list has its own set of requirements. To ensure compliance with UK regulations, companies importing medicines must follow specific guidelines outlined by the Medicines and Healthcare products Regulatory Agency (MHRA). In this blog, we will walk through the key steps and requirements for importing medicines from ap

Following the regulatory changes post-Brexit, the implementation of the Windsor Framework aims to enhance the efficiency of the supply chain and licensing processes for medicines throughout the UK, encompassing Northern Ireland. The framework guarantees that Medicines and Healthcare products Regulatory Agency (MHRA) approval and licensing can be conducted uniformly across the UK and introduces significant modifications concerning the labeling and packaging of medicinal produc

The Medicines and Healthcare products Regulatory Agency (MHRA) plays a pivotal role in ensuring the safety and quality of medicinal products in the UK. Its guidelines for Good Distribution Practice (GDP) are critical for companies involved in the supply chain of pharmaceuticals. Recently, the MHRA has updated these guidelines, reflecting changes that aim to enhance the distribution network’s integrity and efficiency. In this blog, we’ll explore these changes, discuss their im